Thursday, November 12, 2009: 12:30 PM
Bayou A (Gaylord Opryland Hotel)
This session covers QbD consideration for processes involving a solid suspended in a liquid phase. Crystallization and parenteral products are the main focus of this session. Contributions of interest are those involving process considerations and modeling, in-situ characterization of the product or incoming material selection.
Topical I: Comprehensive Quality by Design to Develop and Manufacture Pharmaceutical Products
(585c) Application of Quality by Design Principles to Development of Freeze-Dried Parenteral Dosage Forms
(585d) On the Optimization of the Cooling Profile in Crystallization Using the Design of Dynamic Experiments Approach
(585e) Quality-by-Design (QbD): Examining the Impact of Process Variables On Particle Size Distribution for a Pharmaceutical Co-Precipitation Process Using Real-Time Lasentec FBRM and PVM Process Monitoring and Design of Experiments (DoE) Approach
See more of this Group/Topical: Topical I: Comprehensive Quality by Design in Pharmaceutical Development and Manufacture